RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.

Henrik Lilljebjörn; Helena Ågerstam; Christina Orsmark Pietras; Marianne Rissler; Hans Ehrencrona; L Nilsson; Johan Richter; Thoas Fioretos

doi:10.1038/leu.2013.324

RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.

Henrik Lilljebjörn, Helena Ågerstam, Christina Orsmark Pietras, Marianne Rissler, Hans Ehrencrona, L Nilsson, Johan Richter, Thoas Fioretos

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

599 Nedladdningar (Pure)

Originalspråk	engelska
Sidor (från-till)	977-979
Tidskrift	Leukemia
Volym	28
Nummer	4
DOI	https://doi.org/10.1038/leu.2013.324
Status	Published - 2014

Ämnesklassifikation (UKÄ)

Cancer och onkologi

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1038/leu.2013.324

NPG_Lilljebjorn_et_al

http://www.ncbi.nlm.nih.gov/pubmed/24186003?dopt=Abstract

Citera det här

@article{cc10e79d34864765962cadd6d364c8bf,

title = "RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.",

author = "Henrik Lilljebj{\"o}rn and Helena {\AA}gerstam and {Orsmark Pietras}, Christina and Marianne Rissler and Hans Ehrencrona and L Nilsson and Johan Richter and Thoas Fioretos",

year = "2014",

doi = "10.1038/leu.2013.324",

language = "English",

volume = "28",

pages = "977--979",

journal = "Leukemia",

issn = "1476-5551",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.

AU - Lilljebjörn, Henrik

AU - Ågerstam, Helena

AU - Orsmark Pietras, Christina

AU - Rissler, Marianne

AU - Ehrencrona, Hans

AU - Nilsson, L

AU - Richter, Johan

AU - Fioretos, Thoas

PY - 2014

Y1 - 2014

U2 - 10.1038/leu.2013.324

DO - 10.1038/leu.2013.324

M3 - Letter

C2 - 24186003

SN - 1476-5551

VL - 28

SP - 977

EP - 979

JO - Leukemia

JF - Leukemia

IS - 4

ER -